BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1586509)

  • 1. Choriocarcinoma. A model for tumour markers.
    Bagshawe KD
    Acta Oncol; 1992; 31(1):99-106. PubMed ID: 1586509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
    Huang SC; Hsieh CY; Ouyang PC
    J Formos Med Assoc; 1991 Jan; 90(1):53-8. PubMed ID: 1679110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
    Kanda K
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of hCG as an early diagnosis of cerebral metastases in choriocarcinoma patients.
    Soma H; Takayama M; Tokoro K; Kikuchi T; Kikuchi K; Saegusa H
    Acta Obstet Gynecol Scand; 1980; 59(5):445-8. PubMed ID: 7446011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use.
    Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
    Contraception; 1998 Apr; 57(4):257-60. PubMed ID: 9649918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choriocarcinoma following ovarian hydatidiform mole: a case report.
    Joneborg U; Papadogiannakis N; Lindell G; Marions L
    J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone-induced elevation of serum hCG in choriocarcinoma: a case report.
    Furuhashi M; Miyabe Y; Katsumata Y; Oda H; Imai N
    Endocr J; 1998 Aug; 45(4):585-90. PubMed ID: 9881911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choriocarcinoma and partial hydatidiform moles.
    Seckl MJ; Fisher RA; Salerno G; Rees H; Paradinas FJ; Foskett M; Newlands ES
    Lancet; 2000 Jul; 356(9223):36-9. PubMed ID: 10892763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCG assays. A plea for uniformity.
    Bock JL
    Am J Clin Pathol; 1990 Mar; 93(3):432-3. PubMed ID: 1689949
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
    Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
    Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors].
    Lechner O; Dirnhofer S; Gerth R; Merz WE; Wick G; Berger P
    Wien Klin Wochenschr; 1995; 107(1):15-9. PubMed ID: 7871785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
    Lösch A; Kainz C
    Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?
    Pautier P; Ghione S; Brailly-Tabard S; Lhommé C; Morice P; Bidart JM
    Hum Reprod; 2001 Nov; 16(11):2434-7. PubMed ID: 11679534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of ultrasensitive and totally specific assays of chorionic gonadotropic hormone and its free subunit].
    Bellet D; Ozturk M; Fernandez H; Lhommé C; Frydman R; Bohuon C; Bidart JM
    Rev Prat; 1990 Jun; 40(18):1677-81. PubMed ID: 1695390
    [No Abstract]   [Full Text] [Related]  

  • 18. Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG.
    Birken S; Krichevsky A; O'Connor J; Schlatterer J; Cole L; Kardana A; Canfield R
    Endocrine; 1999 Apr; 10(2):137-44. PubMed ID: 10451222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Choriogonadotrophic hormone and placental tumors].
    Amiel JL; Droz JP; Ben Ayed F
    Ann Endocrinol (Paris); 1984; 45(4-5):231-3. PubMed ID: 6535444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.